Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells.
Lichtenstein DA, Schischlik F, Shao L, Steinberg SM, Yates B, Wang HW, Wang Y, Inglefield J, Dulau-Florea A, Ceppi F, Hermida LC, Stringaris K, Dunham K, Homan P, Jailwala P, Mirazee J, Robinson W, Chisholm KM, Yuan C, Stetler-Stevenson M, Ombrello AK, Jin J, Fry TJ, Taylor N, Highfill SL, Jin P, Gardner RA, Shalabi H, Ruppin E, Stroncek DF, Shah NN. Lichtenstein DA, et al. Among authors: stringaris k. Blood. 2021 Dec 16;138(24):2469-2484. doi: 10.1182/blood.2021011898. Blood. 2021. PMID: 34525183 Free PMC article. Clinical Trial.
A subset of virus-specific CD161+ T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML.
Alsuliman A, Muftuoglu M, Khoder A, Ahn YO, Basar R, Verneris MR, Muranski P, Barrett AJ, Liu E, Li L, Stringaris K, Armstrong-James D, Shaim H, Kondo K, Imahashi N, Andersson B, Marin D, Champlin RE, Shpall EJ, Rezvani K. Alsuliman A, et al. Among authors: stringaris k. Blood. 2017 Feb 9;129(6):740-758. doi: 10.1182/blood-2016-05-713347. Epub 2016 Nov 7. Blood. 2017. PMID: 27821506 Free PMC article.
KIR gene haplotype: an independent predictor of clinical outcome in MDS patients.
Stringaris K, Marin D, Barrett AJ, Hills R, Sobieski C, Cao K, Saltarrelli JG, Daher M, Shaim H, Smith N, Linch D, Gale R, Allen C, Sekine T, Mehta R, Champlin R, Shpall EJ, Kantarjian H, Garcia-Manero G, Rezvani K. Stringaris K, et al. Blood. 2016 Dec 15;128(24):2819-2823. doi: 10.1182/blood-2016-05-713099. Epub 2016 Oct 19. Blood. 2016. PMID: 27760759 Free PMC article.
Intrabone transplantation of CD34+ cells with optimized delivery does not enhance engraftment in a rhesus macaque model.
Stringaris K, Hoyt RF, Davidson-Moncada JK, Pantin JM, Tisdale JF, Uchida N, Raines LN, Reger R, Sato N, Dunbar CE, Hunt TJ, Clevenger RR, Krouse A, Metzger ME, Bonifacino AC, Telford W, Choyke PL, Engels T, Donahue RE, Childs RW. Stringaris K, et al. Blood Adv. 2020 Dec 22;4(24):6148-6156. doi: 10.1182/bloodadvances.2020003040. Blood Adv. 2020. PMID: 33351110 Free PMC article.
Donor KIR Genes 2DL5A, 2DS1 and 3DS1 are associated with a reduced rate of leukemia relapse after HLA-identical sibling stem cell transplantation for acute myeloid leukemia but not other hematologic malignancies.
Stringaris K, Adams S, Uribe M, Eniafe R, Wu CO, Savani BN, Barrett AJ. Stringaris K, et al. Biol Blood Marrow Transplant. 2010 Sep;16(9):1257-64. doi: 10.1016/j.bbmt.2010.03.004. Epub 2010 Mar 17. Biol Blood Marrow Transplant. 2010. PMID: 20302958 Free PMC article.
Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD.
Khoder A, Sarvaria A, Alsuliman A, Chew C, Sekine T, Cooper N, Mielke S, de Lavallade H, Muftuoglu M, Fernandez Curbelo I, Liu E, Muraro PA, Alousi A, Stringaris K, Parmar S, Shah N, Shaim H, Yvon E, Molldrem J, Rouce R, Champlin R, McNiece I, Mauri C, Shpall EJ, Rezvani K. Khoder A, et al. Among authors: stringaris k. Blood. 2014 Sep 25;124(13):2034-45. doi: 10.1182/blood-2014-04-571125. Epub 2014 Jul 22. Blood. 2014. PMID: 25051962 Free PMC article.
Azacitidine maintenance after allogeneic hematopoietic cell transplantation for MDS and AML.
El Chaer F, Borate U, Duléry R, Holtan SG, Law AD, Muffly L, Nassereddine S, Shallis RM, Stringaris K, Taylor J, Devine SM, Mohty M, Hourigan CS. El Chaer F, et al. Among authors: stringaris k. Blood Adv. 2021 Mar 23;5(6):1757-1759. doi: 10.1182/bloodadvances.2020003839. Blood Adv. 2021. PMID: 33755090 Free PMC article. No abstract available.
Tyrosine kinase inhibitors impair B-cell immune responses in CML through off-target inhibition of kinases important for cell signaling.
de Lavallade H, Khoder A, Hart M, Sarvaria A, Sekine T, Alsuliman A, Mielke S, Bazeos A, Stringaris K, Ali S, Milojkovic D, Foroni L, Chaidos A, Cooper N, Gabriel I, Apperley J, Belsey S, Flanagan RJ, Goldman J, Shpall EJ, Kelleher P, Marin D, Rezvani K. de Lavallade H, et al. Among authors: stringaris k. Blood. 2013 Jul 11;122(2):227-38. doi: 10.1182/blood-2012-11-465039. Epub 2013 May 29. Blood. 2013. PMID: 23719297 Free PMC article.
41 results